Ameliorating effect of SA4503, a novel σ1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats

European Journal of Pharmacology

Volumn 315, Issue 1, 1996, Pages 1-10

  Senda, Toshihiko ^a   Matsuno, Kiyoshi ^a   Okamoto, Kazuyoshi ^a   Kobayashi, Tetsuya ^a   Nakata, Katsuhiko ^a   Mita, Shiro ^a  

^a SANTEN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

1 Receptor agonist; Basal forebrain lesion; Cognitive enhancer; Passive avoidance task; Rat; SA4503 (1 (3,4 dimethoxyphenethyl) 4 (3 phenylpropyl)piperazine dihydrochloride); Scopolamine

Indexed keywords

1 (3,4 DIMETHOXYPHENETHYL) 4 (3 PHENYLPROPYL)PIPERAZINE; 2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; HALOPERIDOL; IBOTENIC ACID; PENTAZOCINE; RECEPTOR SUBTYPE; SCOPOLAMINE; SIGMA OPIATE RECEPTOR; TACRINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CHOLINERGIC SYSTEM; COGNITION; CONTROLLED STUDY; DRUG EFFECT; GUINEA PIG; MALE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL;

ANIMALS; AVOIDANCE LEARNING; GUINEA PIGS; IBOTENIC ACID; MALE; MEMORY; MEMORY DISORDERS; NOOTROPIC AGENTS; PAIN MEASUREMENT; PENTAZOCINE; PIPERAZINES; PROSENCEPHALON; RATS; RATS, INBRED F344; RATS, WISTAR; RECEPTORS, SIGMA; SCOPOLAMINE; TACRINE;

EID: 0030574257     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00572-9     Document Type: Article

References (59)

1. Bartus, R.T., C. Flicker, R.L. Dean, M. Pontecorvo, J.C. Figueiredo and S.K. Fisher, 1985, Selective memory loss following nucleus basalis lesions: long term behavioral recovery despite persistent cholinergic deficiencies, Pharmacol. Biochem. Behav. 23, 125.
2. Becker, R., 1991, Therapy of the cognitive deficit in Alzheimer's disease: the cholinergic system, in: Cholinergic Basis for Alzheimer Therapy, eds. R. Becker and E. Giacobini (Birkhauser, Boston, MA) p. 1.
3. Bowen, D.M., S.J. Allen, J.S. Benton, M.J. Goodheart, E.A. Haan, A.M. Palmer, N.R. Sims, C.C.T. Smith, J.A. Spillane, M.M. Esiri, D. Neary, J.S. Snowdon, G.K. Wilcock and A.N. Davison, 1983, Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease, J. Neurochem. 41, 266.
4. 3H]dopamine binding associated with dopamine receptors in calf brain membranes, Mol. Pharmacol. 12, 800.
5. Carroll, F.I., P. Abraham, K. Parham, X. Bai, X. Zhang, G.A. Brine, S.W. Mascarella, B.R. Martin, E.L. May, C. Sauss, L. Di Paolo, P. Wallace, J.M. Walker and W.D. Bowen, 1992, Enantiomeric N-substituted N-normetazocines: a comparative study of affinities at σ, PCP, and μ opioid receptors, J. Med. Chem. 35, 2812.
6. 1 binding sites in guinea pig brain, Eur. J. Pharmacol. 251, R1.
7. Chapin, D.S. and J.A. Nielsen, 1988, Tetrahydroaminoacridine (THA) effects on behavior in rodents, Soc. Neurosci. Abstr. 14, 1070.
8. Collerton, D., 1986, Cholinergic function and intellectual decline in Alzheimer's disease, Neuroscience 19, 1.
9. Contreras, P.C., M.L. Contreras, R.P. Compton and T.L. O'Donohue, 1988, Biochemical and behavioral characterization of PCP and sigma receptors, in: Sigma and Phencyclidine-like Compounds as Molecular Probes in Biology, eds. E.F. Domino and J.-M. Kamenka (NPP Books, Ann Arbor, MI) p. 327.
10. Deutsch, J.A., 1983, The cholinergic synapse and the site of memory, in: The Physiological Basis of Memory, ed. J.A. Deutsch (Academic Press, New York, NY) p. 367.
11. Etienne, P., Y. Robitaille, P. Wood, S. Gauthier, N.P.V. Nair and R. Quirion, 1986, Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease, Neuroscience 19, 1279.
12. Ferris, C.D., D.J. Hirsch, B.P. Brooks and S.H. Snyder, 1991, σ Receptors: from molecule to man, J. Neurochem. 57, 729.
13. Flicker, C., R.L. Dean, D.L. Watkins, S.K. Fisher and R.T. Bartus, 1983, Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat, Pharmacol. Biochem. Behav. 18, 973.
14. Flood, J.F. and A. Cherkin, 1986, Scopolamine effects on memory retention in mice: a model of dementia? Behav. Neural. Biol. 45, 169.
15. 3H]DOPA in various regions of the brain, J. Neurochem. 13, 655.
16. Gottfries, C.G., 1985, Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment. Psychopharmacology 86, 245.
17. Hellewell, S.B. and W.D. Bowen, 1990, A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain, Brain Res. 527, 244.
18. Ichihara, K., T. Nabeshima and T. Kameyama, 1988, Opposite effects induced by low and high doses of apomorphine on single-trial passive avoidance learning in mice, Pharmacol. Biochem. Behav. 30, 107.
19. 2 receptors, Eur. J. Pharmacol. 213, 243.
20. Itzhak, Y., 1994, Multiple sigma binding sites in the brain, in: Sigma Receptors, ed. Y. Itzhak (Academic Press, San Diego, CA) p. 113.
21. Junien, J.L., M. Gue, X. Pascaud, J. Fioramonti and L. Bueno, 1990, Selective stimulation of colonic motor response to a meal by σ ligands in dogs, Gastroenterology 99, 684.
22. 3H]acetylcholine release from rat hippocampal slices, Eur. J. Pharmacol. 200, 343.
23. Kameyama, T., T. Nabeshima and Y. Noda, 1986, Cholinergic modulation of memory for step-down type passive avoidance task in mice, Res. Commun. Psychol. Psychiatry Behav. 11, 193.
24. Kobayashi, T., K. Matsuno and S. Mita, 1996a, Regional differences of the effect of σ receptor ligands on the acetylcholine release in the rat brain, J. Neural Transm. 103, 661.
25. 1 receptor agonist, in the rat brain, J. Pharmacol. Exp. Ther. (in press).
26. Kwo-On-Yuen, P., R. Mandel, A.D. Chen and L.J. Thal, 1990, Tetrahydroaminoacridine improves the spatial acquisition deficit produced by nucleus basalis lesions in rats, Exp. Neurol. 108, 221.
27. 2 binding in rat brain, Eur. J. Pharmacol. 259, 65.
28. Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193, 265.
29. Mandel, R.J. and L.J. Thal, 1988, Physostigmine improves water maze performance following nucleus basalis magnocellularis lesions in rats, Psychopharmacology 96, 421.
30. Matsuno, K., K. Matsunaga and S. Mita, 1992, Increase of extracellular acetylcholine level in rat frontal cortex induced by (+)N-allylnormetazocine as measured by brain microdialysis, Brain Res. 575, 315.
31. Matsuno, K., K. Matsunaga, T. Senda and S. Mita, 1993a, Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex, J. Pharmacol. Exp. Ther. 265, 851.
32. 2 antagonists on drug-induced impairment of passive avoidance response in mice: comparison with acetylcholinesterase inhibitors, Psychopharmacology 112, 134.
33. Matsuno, K., T. Senda and S. Mila, 1993c, Correlation between potentiation of neurogenic twitch contraction and benzomorphan σ receptor binding potency in the mouse vas deferens, Eur. J. Pharmacol. 231, 451.
34. Matsuno, K., T. Senda, K. Matsunaga and S. Mita, 1994, Ameliorating effects of σ receptor ligands on the impairment of passive avoidance tasks in mice: involvement in the central acetylcholinergic system, Eur. J. Pharmacol. 261, 43.
35. 1 receptor in (+)-N-allylnormetazocine-stimulated hippocampal cholinergic functions in rats, Brain Res. 690, 200.
36. 1 receptor agonist, Eur. J. Pharmacol. 306, 271.
37. 1 receptor agonistic properties, Behav. Brain Res. (in press).
38. Matsuoka, N., N. Maeda, M. Yamazaki, Y. Ohkubo and I. Yamaguchi, 1992, Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks, J. Pharmacol. Exp. Ther. 263, 436.
39. Maurice, T., M. Hiramatsu, J. Itoh, T. Kameyama, T. Hasegawa and T. Nabeshima, 1994a, Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia, Brain Res. 647, 44.
40. Maurice, T., M. Hiramatsu, T. Kameyama, T. Hasegawa and T. Nabeshima, 1994b, Behavioral evidence for a modulating role of σ ligands in memory processes. II. Reversion of carbon monoxide-induced amnesia, Brain Res. 647, 57.
41. Miyamoto, M., J. Kato, S. Narumi and A. Nagaoka, 1987, Characteristics of memory impairment following lesioning of the basal forebrain and medial septal nucleus in rats, Brain Res. 419, 19.
42. 3 dorsal hippocampus by sigma ligands, J. Pharmacol. Exp. Ther. 261, 123.
43. Nabeshima, T., S. Ogawa, H. Nishimura, K. Fuji, T. Kameyama and Y. Sasaki, 1991, Staurosporine facilitates recovery from the basal forebrain-lesion-induced impairment of learning and deficit of cholinergic neuron in rats, J. Pharmacol. Exp. Ther. 257, 562.
44. Okuyama, S., Y. Imagawa, S. Ogawa, H. Araki, A. Ajima, M. Tanaka, M. Muramatsu, A. Nakazato, K. Yamaguchi, M. Yoshida and S. Otomo, 1993, NE-100, a novel sigma receptor ligand: in vivo tests, Life Sci. 53, 285.
45. Pascaud, X., J.P. Defaux, C. Roze and J.L. Junien, 1990, Effect of selective sigma ligands on duodenal alkaline secretion in the rat, J. Pharmacol. Exp. Ther. 255, 1354.
46. Paxinos, G. and C. Watson, 1986, The rat brain in Stereotaxic Coordinates, 2nd Ed. (Academic Press, New York).
47. Roman, F.J., X. Pascaud, B. Martin, D. Vauché and J.L. Junien, 1990, JO1784, a potent and selective ligand for rat and mouse brain σ-sites, J. Pharm. Pharmacol. 42, 439.
48. Senda, T., K. Matsuno, T. Kobayashi and K. Nakata, 1995a, Reduction of the scopolamine-induced impairment of passive avoidance tasks by σ receptor ligands in mice, Jpn. J. Pharmacol. Suppl. 67, 296.
49. Senda, T., K. Matsuno and S. Mita, 1995b, Differences in the high affinity sites of σ receptors between guinea pig and rat brain. Neurosci. Res. Commun. 17, 97.
50. Siniscalchi, A., P. Cristofori and E. Veratti, 1987, Influence of N-allylnormetazocine on acetylcholine release from brain slices: involvement of muscarinic receptors, Naunyn-Schmiedeberg's Arch. Pharmacol. 336, 425.
51. Smith, G., 1988, Animal models of Alzheimer's disease: experimental cholinergic denervation, Brain Res. Rev. 13, 103.
52. Steinfels, G.F., G.P. Alberici, S.W. Tam and L. Cook, 1988, Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligand (+)-pentazocine, Neuropsychopharmacology 1, 321.
53. Su, T.-P., 1991, σ Receptors, putative links between nervous, endocrine and immune systems, Eur. J. Biochem. 200, 633.
54. Summers, W.K., J.O. Viesselman, G.M. Marsh and K. Candelora, 1981, Use of THA in treatment of Alzheimer-like dementia: pilot study in twelve patients, Biol. Psychiatry 16, 145.
55. Summers, W.K., L.V. Majovski, G.M. Marsh, K. Tachiki and A. Kling, 1986, Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type, New Engl. J. Med. 315, 1241.
56. Tam, S.W., G.F. Steinfels and L. Cook, 1988, Biochemical and behavioral aspects of sigma and phencyclidine receptors: similarities and differences, in: Sigma and Phencyclidine-Like Compounds as Molecular Probes in Biology, eds. E.F. Domino and J.-M. Kamenka (NPP Books, Ann Arbor, MI) p. 383.
57. Walker, J.M., W.D. Bowen, P.O. Walker, R.R. Matsumoto, B. De Costa and K.C. Rice, 1990, Sigma receptors: biology and function, Pharmacol. Rev. 42, 355.
58. Yamazaki, M., N. Matsuoka, N. Maeda, K. Kuratani, Y. Ohkubo and I. Yamaguchi, 1995, FR121196, a potential antidementia drug, ameliorates the impaired memory of rat in the Morris water maze, J. Pharmacol. Exp. Ther. 272, 256.
59. Yoshida, S. and N. Suzuki, 1993, Antiamnesic and cholinomimetic side-effects of the cholinesterase inhibitors, physostigmine, tacrine and NIK-247 in rats, Eur. J. Pharmacol. 250, 117.